Minimed Group, Inc. (MMED)

Minimed Group Income Statement

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Oct 24, 2025	Apr 25, 2025	Apr 26, 2024	Apr 28, 2023
Revenue	2,886	2,715	2,469	2,245
Revenue Growth (YoY)	28.55%	9.96%	9.98%	-
Cost of Revenue	1,247	1,187	1,031	929
Gross Profit	1,639	1,528	1,438	1,316
Selling, General & Admin	1,119	1,080	1,057	960
Research & Development	455	436	437	429
Other Operating Expenses	4	-8	11	-12
Operating Expenses	1,578	1,508	1,505	1,377
Operating Income	61	20	-67	-61
Other Non Operating Income (Expenses)	-3	-1	-1	-6
EBT Excluding Unusual Items	58	19	-68	-67
Merger & Restructuring Charges	-	-	-1	-8
Legal Settlements	-182	-165	-	-
Pretax Income	-124	-146	-69	-75
Income Tax Expense	72	52	38	16
Earnings From Continuing Operations	-196	-198	-107	-91
Minority Interest in Earnings	-15	-15	-5	-5
Net Income	-211	-213	-112	-96
Net Income to Common	-211	-213	-112	-96
Free Cash Flow	-207	-53	-107	-173
Gross Margin	56.79%	56.28%	58.24%	58.62%
Operating Margin	2.11%	0.74%	-2.71%	-2.72%
Profit Margin	-7.31%	-7.85%	-4.54%	-4.28%
Free Cash Flow Margin	-7.17%	-1.95%	-4.33%	-7.71%
EBITDA	214	163	62	54
EBITDA Margin	7.41%	6.00%	2.51%	2.40%
D&A For EBITDA	153	143	129	115
EBIT	61	20	-67	-61
EBIT Margin	2.11%	0.74%	-2.71%	-2.72%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q